
NVRO Valuation
Nevro Corp
- Overview
- Forecast
- Valuation
- Earnings
NVRO Relative Valuation
NVRO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, NVRO is overvalued; if below, it's undervalued.
Historical Valuation
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
0.96
P/B
Median3y
2.59
Median5y
6.60
-13.21
FCF Yield
Median3y
-11.44
Median5y
-7.05
Competitors Valuation Multiple
The average P/S ratio for NVRO's competitors is 138.12, providing a benchmark for relative valuation. Nevro Corp Corp (NVRO) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of -6.69%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch

ACTU
Actuate Therapeutics Inc
7.260
USD
+3.86%

ABAT
American Battery Technology Co
3.155
USD
-6.38%

GLSI
Greenwich Lifesciences Inc
11.570
USD
+0.70%

INFU
InfuSystem Holdings Inc
6.010
USD
+1.69%

VXRT
Vaxart Inc
0
USD
-33.44%

MYFW
First Western Financial Inc
23.405
USD
-4.70%

INSG
Inseego Corp
7.360
USD
+1.52%

LYEL
Lyell Immunopharma Inc
12.420
USD
+19.31%

BHR
Braemar Hotels & Resorts Inc
2.380
USD
-0.42%

MED
Medifast Inc
14.900
USD
-1.39%
FAQ

Is Nevro Corp (NVRO) currently overvalued or undervalued?
Nevro Corp (NVRO) is now in the Fair zone, suggesting that its current forward PS ratio of NaN is considered Fairly compared with the five-year average of -28.10. The fair price of Nevro Corp (NVRO) is between to according to relative valuation methord.

What is Nevro Corp (NVRO) fair value?

How does NVRO's valuation metrics compare to the industry average?

What is the current P/B ratio for Nevro Corp (NVRO) as of Jul 27 2025?

What is the current FCF Yield for Nevro Corp (NVRO) as of Jul 27 2025?

What is the current Forward P/E ratio for Nevro Corp (NVRO) as of Jul 27 2025?
